Neil Averitt commentary: Many reasons to act on insulin pricing

Washington, D.C. (March 15, 2022) -- A conscious parallelism case may be in your future. For the last 15 years, the country has watched in shock and awe as the price of insulin has moved inexorably upward, far outpacing inflation and reaching up to 30 times the cost of manufacturing the product....

Related Sections